Key research
PCV associated disease
The effect of vaccination against porcine circovirus type 2 in pigs
Ingelvac CircoFLEX® was evaluated on a farms where pigs were known to be infected with PCV2 but where the predominant clinical problem was respiratory disease in middle to late finishing. A total of 1542 pigs were allocated to two groups one of which was vaccinated with Ingelvac CircoFLEX® while the other received a placebo.
Vaccination resulted in a significant
- Reduction in viral load (p<0001) and duration of viraemia (p<0001)
- Reduction in mortality (p=0.1507)
- Improvement in average daily weight gain of 649 – 667 g/day (p<0001) and time to market 170.4– 164.8 days (p<0001)
Vaccination of pigs with Ingelvac CircoFLEX® significantly improved the growth performance of pigs affected with late occurring porcine respiratory disease complex (PRDC).
Fachinger V et al. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex (PRDC). Vaccine 2008;26(11):1488-1499
A pdf of this article may be purchased from www.sciencedirect.com